bf/NASDAQ:AUGX_icon.jpeg

COM:AUGMEDIX

Augmedix, Inc.

  • Stock

Last Close

2.35

01/10 19:57

Market Cap

43.80M

Beta: -

Volume Today

23.00K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.11M
-
171.50K
91.85%
-1.91M
1,211.66%
average payables
449.95K
-
812K
80.47%
1.46M
80.30%
average receivables
2.49M
-
4.94M
98.06%
6.77M
37.09%
book value per share
-2.42
-
0.12
104.80%
0.82
604.36%
0.04
95.22%
capex per share
-0.03
-
-0.02
21.38%
-0.02
12.26%
-0.04
78.07%
capex to depreciation
-0.87
-
-0.75
13.95%
-0.88
18.49%
-1.64
86.02%
capex to operating cash flow
0.06
-
0.04
20.04%
0.03
26.86%
0.08
155.43%
capex to revenue
-0.06
-
-0.04
32.71%
-0.03
29.77%
-0.05
65.12%
cash per share
0.36
-
0.77
116.20%
1.44
86.10%
0.59
59.14%
days of inventory on hand
77.43
-
83.29
7.57%
-56.08
167.33%
-41.81
25.44%
days payables outstanding
24.81
-
9.76
60.67%
40.98
320.00%
33.60
18.01%
days sales outstanding
59.27
-
59.63
0.62%
118.20
98.21%
74.98
36.57%
debt to assets
0.80
-
0.54
33.23%
0.32
40.94%
0.59
85.78%
debt to equity
-0.19
-
4.79
2,571.27%
0.69
85.59%
13.48
1,853.65%
dividend yield
earnings yield
-0.17
-
-0.11
34.10%
-0.19
71.72%
-0.45
141.21%
-0.00
99.98%
enterprise value
137.33M
-
128.51M
6.42%
64.33M
49.94%
56.14M
12.73%
enterprise value over ebitda
-9.32
-
-9.39
0.71%
-3.59
61.79%
-2.51
30.03%
ev to operating cash flow
-9.38
-
-8.92
4.82%
-3.46
61.23%
-3.35
3.27%
ev to sales
9.73
-
7.80
19.91%
2.90
62.77%
1.81
37.47%
free cash flow per share
-0.58
-
-0.56
2.73%
-0.66
18.58%
-0.49
26.84%
-0.00
99.93%
free cash flow yield
-0.12
-
-0.11
2.73%
-0.21
88.22%
-0.31
47.73%
-0.00
99.98%
graham net net
-2.55
-
-0.03
98.65%
0.62
1,914.14%
-0.17
127.39%
graham number
6.74
-
1.20
82.22%
3.31
176.04%
0.79
76.10%
income quality
0.79
-
0.92
16.55%
1.04
12.87%
0.69
34.13%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-5.95
-
-9.42
58.30%
-7.18
23.80%
-10.77
49.92%
8.34
177.42%
interest debt per share
0.57
-
0.61
6.33%
0.65
6.68%
0.58
10.42%
inventory turnover
4.71
-
4.38
7.04%
-6.51
248.52%
-8.73
34.12%
invested capital
-0.19
-
4.79
2,571.27%
0.69
85.59%
13.48
1,853.65%
market cap
134.32M
-
134.32M
0%
91.08M
32.19%
58.37M
35.91%
257.09B
440,320.24%
net current asset value
-66.53M
-
1.96M
102.94%
20.77M
960.03%
-3.83M
118.46%
net debt to ebitda
-0.20
-
0.42
307.64%
1.49
251.40%
0.10
93.31%
net income per share
-0.83
-
-0.55
34.10%
-0.59
8.18%
-0.71
19.46%
-0.00
99.94%
operating cash flow per share
-0.55
-
-0.54
1.68%
-0.64
19.96%
-0.45
30.29%
-0.00
99.92%
payables turnover
14.71
-
37.41
154.29%
8.91
76.19%
10.86
21.96%
receivables turnover
6.16
-
6.12
0.61%
3.09
49.55%
4.87
57.66%
research and ddevelopement to revenue
0.49
-
0.27
44.53%
0.30
9.82%
0.33
8.90%
0.25
24.06%
return on tangible assets
-1.42
-
-0.53
62.87%
-0.33
37.06%
-0.79
137.49%
revenue per share
0.53
-
0.61
16.84%
0.77
24.93%
0.83
7.84%
0.00
99.88%
roe
0.34
-
-4.72
1,474.24%
-0.72
84.64%
-18.09
2,397.42%
roic
0.39
-
-0.72
285.69%
-0.43
39.78%
-1.05
144.27%
sales general and administrative to revenue
0.77
-
0.70
8.85%
0.62
11.54%
0.55
12.02%
0.41
24.71%
shareholders equity per share
-2.42
-
0.12
104.80%
0.82
604.36%
0.04
95.22%
stock based compensation to revenue
0.03
-
0.04
43.99%
0.06
54.39%
0.07
9.11%
tangible asset value
-65.14M
-
3.12M
104.80%
23.68M
658.13%
1.47M
93.81%
tangible book value per share
-2.42
-
0.12
104.80%
0.82
604.36%
0.04
95.22%
working capital
1.49M
-
10.30M
591.76%
41.16M
299.75%
19.52M
52.57%

All numbers in (except ratios and percentages)